Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(30%)
Results Posted
100%(5 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
3
30%
Ph early_phase_1
2
20%
Ph phase_2
3
30%
Ph not_applicable
2
20%

Phase Distribution

5

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
2(20.0%)
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
3(30.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Active, not recruiting2
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (20.0%)
Phase 13 (30.0%)
Phase 23 (30.0%)
N/A2 (20.0%)

Trials by Status

completed550%
recruiting110%
terminated110%
active_not_recruiting220%
withdrawn110%

Recent Activity

3 active trials
Showing 5 of 10
recruitingearly_phase_1

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

NCT03422731
active_not_recruitingphase_2

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

NCT02392429
terminatedphase_2

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

NCT04221438
active_not_recruitingphase_1

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

NCT01251874
completedphase_1

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

NCT00880074
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT03422731Early Phase 1

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

Recruiting
NCT02392429Phase 2

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Active Not Recruiting
NCT04221438Phase 2

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Terminated
NCT01251874Phase 1

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

Active Not Recruiting
NCT00880074Phase 1

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

Completed
NCT03613259Early Phase 1

Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma

Withdrawn
NCT02167204Not Applicable

18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors

Completed
NCT01928186Not Applicable

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Completed
NCT00499135Phase 1

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Completed
NCT00062374Phase 2

Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10